Ep50: The Future of DTx isn’t DTx

Release Date:

In this episode, we hear from Ali Hashemi, Co-founder of meta[bolic]. In their own words, meta[bolic] is a hybrid digital therapeutics company focused on addressing the global metabolic health crisis.

In this episode, we cover:

The initial business hypothesis of GluCare and meta[bolic]

Digital therapeutics vs disease management

Why we are becoming more metabolically unstable than previous generations

The global metabolic problem

Patient experience on the meta[bolic] platform


Guest Links and Resources:

Connect with Ali Hashemi on LinkedIn


Visit Glucare.Health



Host Links:

Connect with Eugene Borukhovich: Twitter | LinkedIn


Connect with Chandana Fitzgerald, MD: Twitter | LinkedIn


Connect with YourCoach.health: Website | Twitter


Check out Shot of Digital Health with Eugene and Jim Joyce: Website | Podcast App


HealthXL: Website | Twitter | Join an Event



Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to:
> Presenting Partner: Amalgam Rx
> Sponsors: Akili | Big Health | Click Therapeutics | Lindus Health

Follow Digital Health Today:
Browse Episodes | Twitter | LinkedIn | Facebook | Instagram

Follow Health Podcast Network:
Browse Shows | LinkedIn | Twitter | Facebook | Instagram

Ep50: The Future of DTx isn’t DTx

Title
Ep50: The Future of DTx isn’t DTx
Copyright
Release Date

flashback